Research Senior Supervisor
[email protected]
Available to mentor
Swati Bhattacharyya
Research Scientist
-
Wang W, Bale S, Wei J, Yalavarthi B, Bhattacharyya D, Yan JJ, Abdala-Valencia H, Xu D, Sun H, Marangoni RG, Herzog E, Berdnikovs S, Miller SD, Sawalha AH, Tsou P-S, Awaji K, Yamashita T, Sato S, Asano Y, Tiruppathi C, Yeldandi A, Schock BC, Bhattacharyya S, Varga J. Nat Commun, 2023 Jan 31; 14 (1): 523Journal ArticleAuthor Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.
DOI:10.1038/s41467-023-36285-7 PMID: 36720888 -
Bale S, Verma P, Varga J, Bhattacharyya S. J Invest Dermatol, 2023 Oct; 143 (10): 1877 - 1885.Journal ArticleExtracellular Matrix-Derived Damage-Associated Molecular Patterns (DAMP): Implications in Systemic Sclerosis and Fibrosis.
DOI:10.1016/j.jid.2023.04.030 PMID: 37452808 -
Bale S, Verma P, Yalavarthi B, Scarneo SA, Hughes P, Amin MA, Tsou P-S, Khanna D, Haystead TA, Bhattacharyya S, Varga J. JCI Insight, 2023 Jul 24; 8 (14):Journal ArticlePharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis.
DOI:10.1172/jci.insight.165358 PMID: 37306632 -
Wang W, Bale S, Wei J, Yalavarthi B, Bhattacharyya D, Yan JJ, Abdala-Valencia H, Xu D, Sun H, Marangoni RG, Herzog E, Berdnikovs S, Miller SD, Sawalha AH, Tsou P-S, Awaji K, Yamashita T, Sato S, Asano Y, Tiruppathi C, Yeldandi A, Schock BC, Bhattacharyya S, Varga J. Nat Commun, 2022 Oct 26; 13 (1): 6358Journal ArticleFibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.
DOI:10.1038/s41467-022-33767-y PMID: 36289219 -
Bhattacharyya S, Midwood KS, Varga J. Semin Cell Dev Biol, 2022 Aug; 128: 130 - 136.Journal ArticleTenascin-C in fibrosis in multiple organs: Translational implications.
DOI:10.1016/j.semcdb.2022.03.019 PMID: 35400564 -
Xu D, Bhattacharyya S, Wang W, Ifergan I, Wong M-YAC, Procissi D, Yeldandi A, Bale S, Marangoni RG, Horbinski C, Miller SD, Varga J. JCI Insight, 2022 Mar 8; 7 (5):Journal ArticlePLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis.
DOI:10.1172/jci.insight.151037 PMID: 35104243 -
Shi B, Wang W, Korman B, Kai L, Wang Q, Wei J, Bale S, Marangoni RG, Bhattacharyya S, Miller S, Xu D, Akbarpour M, Cheresh P, Proccissi D, Gursel D, Espindola-Netto JM, Chini CCS, de Oliveira GC, Gudjonsson JE, Chini EN, Varga J. iScience, 2021 Jan 22; 24 (1): 101902Journal ArticleTargeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis.
DOI:10.1016/j.isci.2020.101902 PMID: 33385109 -
Wang W, Bhattacharyya S, Marangoni RG, Carns M, Dennis-Aren K, Yeldandi A, Wei J, Varga J. J Scleroderma Relat Disord, 2020 Feb; 5 (1): 40 - 50.Journal ArticleThe JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib.
DOI:10.1177/2397198319865367 PMID: 35382402
